Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07226986
What this trial is testing

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

Who this might be right for
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals 123
Testing effectiveness (Phase 2)Temporarily pausedNCT05361915
What this trial is testing

Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Metastatic
Sorrento Therapeutics, Inc. 100
Early research (Phase 1)Ended earlyNCT04740034
What this trial is testing

AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 42
Testing effectiveness (Phase 2)Ended earlyNCT03549338
What this trial is testing

Sym004 Versus Futuximab or Modotuximab in Patients With mCRC

Who this might be right for
Metastatic Colorectal CancerColorectal Cancer MetastaticCarcinoma
Symphogen A/S 2
Not applicableEnded earlyNCT03011749
What this trial is testing

Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients

Who this might be right for
Metastatic Prostate Carcinoma
Rigshospitalet, Denmark 6
Testing effectiveness (Phase 2)Study completedNCT00080743
What this trial is testing

Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 2
Early research (Phase 1)Study completedNCT00903734
What this trial is testing

An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 16
Early research (Phase 1)WithdrawnNCT02866916
What this trial is testing

Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA)

Who this might be right for
Prostatic Cancer, Castration-Resistant
Institut Claudius Regaud
Not applicableWithdrawnNCT02130947
What this trial is testing

Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
UNC Lineberger Comprehensive Cancer Center
Not applicableStudy completedNCT03927287
What this trial is testing

Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer

Who this might be right for
MetastasisCastration-resistant Prostate CancerDeath
Rabin Medical Center 822
Post-approval studies (Phase 4)UnknownNCT01820026
What this trial is testing

Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis

Who this might be right for
Cirrhosis
University of Roma La Sapienza 96
Testing effectiveness (Phase 2)Ended earlyNCT02122003
What this trial is testing

Second Line Sorafenib After Pazopanib in Patients With RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 16
Testing effectiveness (Phase 2)Looking for participantsNCT05113537
What this trial is testing

Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+4 more
Vadim S Koshkin 30
Testing effectiveness (Phase 2)Study completedNCT04564027
What this trial is testing

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Who this might be right for
Advanced Solid Tumours
AstraZeneca 54
Testing effectiveness (Phase 2)WithdrawnNCT07025512
What this trial is testing

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

Who this might be right for
Metastatic Castration Resistant Prostate CancerCytopeniaAnemia+1 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT07133256
What this trial is testing

Effects of Aerobic Versus Resistance Training on Bone Metabolism in Stage 3-4 Chronic Kidney Disease

Who this might be right for
OsteopeniaBone Metabolism DisordersChronic Kidney Disease (Stage 3-4)+1 more
Sinai University 60
Not applicableStudy completedNCT02803437
What this trial is testing

Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer 334
Not applicableStudy completedNCT00924937
What this trial is testing

CORonary Diet Intervention With Olive Oil and Cardiovascular PREVention

Who this might be right for
Myocardial InfarctionUnstable AnginaMalignancy+3 more
Hospital Universitario Reina Sofia de Cordoba 1,002
Large-scale testing (Phase 3)Looking for participantsNCT07365995
What this trial is testing

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
BioNTech SE 736
Not applicableNot Yet RecruitingNCT07154914
What this trial is testing

A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cance
Anhui Medical University 396
Next Page